1987
DOI: 10.1203/00006450-198708000-00006
|View full text |Cite
|
Sign up to set email alerts
|

The in Vivo Effect of Bilirubin and Sulfisoxazole on Cerebral Oxygen, Glucose, and Lactate Metabolism in Newborn Piglets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
6
1

Year Published

1995
1995
2017
2017

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 19 publications
0
6
1
Order By: Relevance
“…In contrast to the results of previous studies [9,26,33], significant reduction in mean arterial pressure and metabolic acidosis were observed in both BG and NG. Since a similar amount of bilirubin was given, and comparable brain bilirubin levels was achieved, the reasons for this discrepancy are difficult to explain.…”
Section: Discussioncontrasting
confidence: 56%
See 1 more Smart Citation
“…In contrast to the results of previous studies [9,26,33], significant reduction in mean arterial pressure and metabolic acidosis were observed in both BG and NG. Since a similar amount of bilirubin was given, and comparable brain bilirubin levels was achieved, the reasons for this discrepancy are difficult to explain.…”
Section: Discussioncontrasting
confidence: 56%
“…Decreased blood-to-brain glucose ratio and increased lactate level in the blood and brain observed in BG also indicate secondarily increased anaerobic glycolysis to compensate for the bilirubin-induced mitochon-Park/Chang/Lee drial damage and energy depletion. However, similar experiments done in guinea pig [31], Gunn rat [32] and newborn piglet [33] failed to document a marked change in cerebral glucose metabolism or oxidative phosphorylation. These discrepancies might be attributable to differences in animal species, bilirubin dosage and duration of exposure.…”
Section: Discussionmentioning
confidence: 90%
“…Indeed, in order to be clinically relevant, we induced a moderate (150–250 μmol/L) and sustained (17 h) HB in a (late) preterm animal. In contrast, previous studies reported data from more severe (from 220 to 1300 μmoles/L) and shorter duration HB (ranging from one injection to 4 h infusion) (Ahlfors et al, 1986 ; Brann et al, 1987 ; Park et al, 2001 ; Mesner et al, 2008 ; Ye et al, 2012 ). To our knowledge, there has been only one previous study on “moderate” HB (100–200 μmoles/L), but with considerably shorter HB duration (2 h) (Roger et al, 1995 ).…”
Section: Discussionmentioning
confidence: 91%
“…Compared to previous animal models of neonatal HB (Ahlfors et al, 1986 ; Brann et al, 1987 ; Park et al, 2001 ; Mesner et al, 2008 ; Ye et al, 2012 ), our preterm ovine model of moderate HB has several unique features. Indeed, in order to be clinically relevant, we induced a moderate (150–250 μmol/L) and sustained (17 h) HB in a (late) preterm animal.…”
Section: Discussionmentioning
confidence: 94%
“…Animals such as rat (7), piglet (8), and rhesus monkey (9) show the increased bilirubin deposition in brain upon drug administration. Extrapolation of results of these studies using an animal model to humans is only useful when the test animal albumin binds bilirubin as well as the drug in the same manner as the human albumin binds.…”
mentioning
confidence: 99%